Small Molecule Innovator API CDMO Market Size, Share & Trends Report

Small Molecule Innovator API CDMO Market Size, Share & Trends Analysis Report By Stage Type (Preclinical, Clinical, Commercial), By Customer Type, By Therapeutic Area, By Region, And Segment Forecasts, 2024 - 2030

Report ID: GVR-4-68040-250-0
Number of Pages: 241
Format: Electronic (PDF)

Historical Range: 2018 - 2023
Industry: Healthcare

Market Segmentation

Small Molecule Innovator API CDMO Stage Type Outlook (Revenue, USD Million, 2018 - 2030)
- Preclinical
- Clinical
  - Phase I
  - Phase II
  - Phase III
- Commercial
Small Molecule Innovator API CDMO Customer Type Outlook (Revenue, USD Million, 2018 - 2030)
- Pharmaceutical
  - Small
  - Medium
  - Large
- Biotechnology
  - Small
  - Medium
  - Large
Small Molecule Innovator API CDMO Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
- Cardiovascular Diseases
- Oncology
- Respiratory Disorders
- Neurology
- Metabolic Disorders
- Infectious Diseases
- Others
Small Molecule Innovator API CDMO Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Stage Type Outlook (Revenue, USD Million, 2018 - 2030)
    - Preclinical
    - Clinical
      - Phase I
      - Phase II
      - Phase III
    - Commercial
  - North America Customer Type Outlook (Revenue in USD Million, 2018 - 2030)
    - Pharmaceutical
      - Small
      - Medium
      - Large
    - Commercial
      - Small
      - Medium
      - Large
  - North America Therapeutic Area Outlook (Revenue in USD Million, 2018 - 2030)
    - Cardiovascular Diseases
    - Oncology
    - Respiratory Disorders
    - Neurology
    - Metabolic Disorders
    - Infectious Diseases
    - Others
  - U.S.
    - U.S. Stage Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - U.S. Customer Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Commercial
        
        Small
        
        Medium
        
        Large
    - U.S. Therapeutic Area Outlook (Revenue in USD Million, 2018 - 2030)
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - Canada
    - Canada Stage Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Canada Customer Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Commercial
        
        Small
        
        Medium
        
        Large
    - Canada Therapeutic Area Outlook (Revenue in USD Million, 2018 - 2030)
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
- Europe
  - Europe Stage Type Outlook (Revenue, USD Million, 2018 - 2030)
    - Preclinical
    - Clinical
      - Phase I
      - Phase II
      - Phase III
    - Commercial
  - Europe Customer Type Outlook (Revenue in USD Million, 2018 - 2030)
    - Pharmaceutical
      - Small
      - Medium
      - Large
    - Commercial
      - Small
      - Medium
      - Large
  - Europe Therapeutic Area Outlook (Revenue in USD Million, 2018 - 2030)
    - Cardiovascular Diseases
    - Oncology
    - Respiratory Disorders
    - Neurology
    - Metabolic Disorders
    - Infectious Diseases
    - Others
  - UK
    - UK Stage Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - UK Customer Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Commercial
        
        Small
        
        Medium
        
        Large
    - UK Therapeutic Area Outlook (Revenue in USD Million, 2018 - 2030)
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - Germany
    - Germany Stage Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Germany Customer Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Commercial
        
        Small
        
        Medium
        
        Large
    - Germany Therapeutic Area Outlook (Revenue in USD Million, 2018 - 2030)
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - France
    - France Stage Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - France Customer Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Commercial
        
        Small
        
        Medium
        
        Large
    - France Therapeutic Area Outlook (Revenue in USD Million, 2018 - 2030)
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - Italy
    - Italy Stage Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Italy Customer Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Commercial
        
        Small
        
        Medium
        
        Large
    - Italy Therapeutic Area Outlook (Revenue in USD Million, 2018 - 2030)
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - Spain
    - Spain Stage Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Spain Customer Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Commercial
        
        Small
        
        Medium
        
        Large
    - Spain Therapeutic Area Outlook (Revenue in USD Million, 2018 - 2030)
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - Denmark
    - Denmark Stage Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Denmark Customer Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Commercial
        
        Small
        
        Medium
        
        Large
    - Denmark Therapeutic Area Outlook (Revenue in USD Million, 2018 - 2030)
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - Sweden
    - Sweden Stage Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Sweden Customer Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Commercial
        
        Small
        
        Medium
        
        Large
    - Sweden Therapeutic Area Outlook (Revenue in USD Million, 2018 - 2030)
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - Norway
    - Norway Stage Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Norway Customer Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Commercial
        
        Small
        
        Medium
        
        Large
    - Norway Therapeutic Area Outlook (Revenue in USD Million, 2018 - 2030)
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
- Asia Pacific
  - Asia Pacific Stage Type Outlook (Revenue, USD Million, 2018 - 2030)
    - Preclinical
    - Clinical
      - Phase I
      - Phase II
      - Phase III
    - Commercial
  - Asia Pacific Customer Type Outlook (Revenue in USD Million, 2018 - 2030)
    - Pharmaceutical
      - Small
      - Medium
      - Large
    - Commercial
      - Small
      - Medium
      - Large
  - Asia Pacific Therapeutic Area Outlook (Revenue in USD Million, 2018 - 2030)
    - Cardiovascular Diseases
    - Oncology
    - Respiratory Disorders
    - Neurology
    - Metabolic Disorders
    - Infectious Diseases
    - Others
  - China
    - China Stage Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - China Customer Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Commercial
        
        Small
        
        Medium
        
        Large
    - China Therapeutic Area Outlook (Revenue in USD Million, 2018 - 2030)
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - Japan
    - Japan Stage Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Japan Customer Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Commercial
        
        Small
        
        Medium
        
        Large
    - Japan Therapeutic Area Outlook (Revenue in USD Million, 2018 - 2030)
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - India
    - India Stage Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - India Customer Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Commercial
        
        Small
        
        Medium
        
        Large
    - India Therapeutic Area Outlook (Revenue in USD Million, 2018 - 2030)
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - Australia
    - Australia Stage Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Australia Customer Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Commercial
        
        Small
        
        Medium
        
        Large
    - Australia Therapeutic Area Outlook (Revenue in USD Million, 2018 - 2030)
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - South Korea
    - South Korea Stage Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - South Korea Customer Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Commercial
        
        Small
        
        Medium
        
        Large
    - South Korea Therapeutic Area Outlook (Revenue in USD Million, 2018 - 2030)
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - Thailand
    - Thailand Stage Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Thailand Customer Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Commercial
        
        Small
        
        Medium
        
        Large
    - Thailand Therapeutic Area Outlook (Revenue in USD Million, 2018 - 2030)
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - Taiwan
    - Taiwan Stage Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Taiwan Customer Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Commercial
        
        Small
        
        Medium
        
        Large
    - Taiwan Therapeutic Area Outlook (Revenue in USD Million, 2018 - 2030)
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
- Latin America
  - Latin America Stage Type Outlook (Revenue, USD Million, 2018 - 2030)
    - Preclinical
    - Clinical
      - Phase I
      - Phase II
      - Phase III
    - Commercial
  - Latin America Customer Type Outlook (Revenue in USD Million, 2018 - 2030)
    - Pharmaceutical
      - Small
      - Medium
      - Large
    - Commercial
      - Small
      - Medium
      - Large
  - Latin America Therapeutic Area Outlook (Revenue in USD Million, 2018 - 2030)
    - Cardiovascular Diseases
    - Oncology
    - Respiratory Disorders
    - Neurology
    - Metabolic Disorders
    - Infectious Diseases
    - Others
  - Brazil
    - Brazil Stage Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Brazil Customer Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Commercial
        
        Small
        
        Medium
        
        Large
    - Brazil Therapeutic Area Outlook (Revenue in USD Million, 2018 - 2030)
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - Mexico
    - Mexico Stage Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Mexico Customer Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Commercial
        
        Small
        
        Medium
        
        Large
    - Mexico Therapeutic Area Outlook (Revenue in USD Million, 2018 - 2030)
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - Argentina
    - Argentina Stage Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Argentina Customer Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Commercial
        
        Small
        
        Medium
        
        Large
    - Argentina Therapeutic Area Outlook (Revenue in USD Million, 2018 - 2030)
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
- Middle East & Africa (MEA)
  - Middle East & Africa (MEA) Stage Type Outlook (Revenue, USD Million, 2018 - 2030)
    - Preclinical
    - Clinical
      - Phase I
      - Phase II
      - Phase III
    - Commercial
  - Middle East & Africa (MEA) Customer Type Outlook (Revenue in USD Million, 2018 - 2030)
    - Pharmaceutical
      - Small
      - Medium
      - Large
    - Commercial
      - Small
      - Medium
      - Large
  - Middle East & Africa (MEA) Therapeutic Area Outlook (Revenue in USD Million, 2018 - 2030)
    - Cardiovascular Diseases
    - Oncology
    - Respiratory Disorders
    - Neurology
    - Metabolic Disorders
    - Infectious Diseases
    - Others
  - South Africa
    - South Africa Stage Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - South Africa Customer Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Commercial
        
        Small
        
        Medium
        
        Large
    - South Africa Therapeutic Area Outlook (Revenue in USD Million, 2018 - 2030)
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - Saudi Arabia
    - Saudi Arabia Stage Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Saudi Arabia Customer Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Commercial
        
        Small
        
        Medium
        
        Large
    - Saudi Arabia Therapeutic Area Outlook (Revenue in USD Million, 2018 - 2030)
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - UAE
    - UAE Stage Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - UAE Customer Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Commercial
        
        Small
        
        Medium
        
        Large
    - UAE Therapeutic Area Outlook (Revenue in USD Million, 2018 - 2030)
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - Kuwait
    - Kuwait Stage Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Kuwait Customer Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Commercial
        
        Small
        
        Medium
        
        Large
    - Kuwait Therapeutic Area Outlook (Revenue in USD Million, 2018 - 2030)
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others
  - Israel
    - Israel Stage Type Outlook (Revenue, USD Million, 2018 - 2030)
      - Preclinical
      - Clinical
        
        Phase I
        
        Phase II
        
        Phase III
      - Commercial
    - Israel Customer Type Outlook (Revenue in USD Million, 2018 - 2030)
      - Pharmaceutical
        
        Small
        
        Medium
        
        Large
      - Commercial
        
        Small
        
        Medium
        
        Large
    - Israel Therapeutic Area Outlook (Revenue in USD Million, 2018 - 2030)
      - Cardiovascular Diseases
      - Oncology
      - Respiratory Disorders
      - Neurology
      - Metabolic Disorders
      - Infectious Diseases
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.